Treatment guided by cerebral oximetry monitoring for the first 72 hours after birth failed to improve survival for extremely preterm infants, the SafeBoosC-III trial found. At 36 weeks postmenstrual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results